Experience the Quality With Free CCP-C Exam Questions That Helps Candidates Pass

The sluggish square-wave response indicates overdamping—air, clot, or compliant/long tubing—producing falsely low systolic and MAP. Troubleshoot before titrating vasoactives: vigorous fast-flush, remove bubbles, straighten/replace compliant tubing, confirm tight connections, re-level at the phlebostatic axis, and re-zero. Correlate again with NIBP and exam. Prematurely escalating pressors risks overtreatment. Removing the line (C) is a fallback if damping persists after corrective steps. Discarding all invasive data (D) forfeits the benefit of beat-to-beat monitoring that is critical in transport. Repeat the square-wave test to confirm improved fidelity, then base therapy on reliable numbers and clinical context.

In hemorrhagic shock, the priority is hemorrhage control and restoring oxygen-carrying capacity. Current trauma resuscitation principles favor damage-control resuscitation: permissive hypotension (e.g., SBP ~80–90 mmHg in non-TBI patients) and early balanced blood product administration (e.g., PRBCs, plasma, platelets in ratios guided by local protocol) rather than large volumes of crystalloids. Excessive crystalloids (A) dilute clotting factors, exacerbate acidosis, and increase mortality. High PEEP and hyperventilation (C) do not address hypovolemia and may reduce venous return. Vasopressors (D) without adequate volume can worsen tissue perfusion and are generally avoided early in hemorrhagic shock, except as a bridge in refractory cases when blood is being obtained. Monitor calcium levels during massive transfusion, maintain normothermia, prevent coagulopathy, and coordinate rapid transport to definitive surgical or interventional control.

Analgesia-first (pain before sedation) improves comfort and reduces sedative needs. Fentanyl provides potent analgesia with relatively stable hemodynamics; it can be titrated to effect and combined with light sedation (e.g., dexmedetomidine or low-dose midazolam). High-dose midazolam (A) increases delirium and hypotension risk and lacks analgesia. Propofol boluses (C) cause hypotension and do not target pain primarily. Ketorolac alone (D) is inadequate, with bleeding/renal risks. CCP-C goals include RASS-targeted sedation, daily awakening when feasible, and multimodal analgesia (acetaminophen, regional techniques at receiving facility). Continuous monitoring for respiratory, hemodynamic, and neurologic effects during transport is mandatory.

Ductal-dependent lesions rely on a patent ductus arteriosus for systemic or pulmonary flow. Hypoxemia refractory to oxygen indicates critical shunting. Prostaglandin E₁ (0.05–0.1 mcg/kg/min) maintains ductal patency and restores circulation. Diuretics (B) worsen perfusion. RSI (C) is not indicated solely for cyanosis and may destabilize. Nitroprusside (D) is contraindicated. CCP-C priorities: start PGE₁ infusion, anticipate apnea/hypotension, prepare for airway management, monitor closely, and expedite transfer to pediatric cardiac surgery center. Early recognition and initiation of PGE₁ are lifesaving.

Croup (subglottic edema) improves with nebulized racemic epinephrine (α-vasoconstriction reduces edema) and systemic steroids (dexamethasone decreases inflammation and relapse). Routine RSI (B) is reserved for impending failure; intubation in croup is challenging and should follow failed medical therapy. Albuterol (C) targets lower airways and is not primary for upper airway edema. Hypertonic saline (D) lacks evidence in croup. CCP-C transport priorities: calm environment, minimal agitation, appropriate oxygen delivery, continuous monitoring, and readiness with appropriately sized ETT (often 0.5–1.0 mm smaller than age-based formula) if deterioration occurs. Observe for rebound after epinephrine; repeat doses may be needed per protocol.